Editorial: Clinical Phytopharmacology
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Baars E, Weiermayer P, Szoke H, van der Werf E Antibiotics (Basel). 2025; 14(1).
PMID: 39858387 PMC: 11762681. DOI: 10.3390/antibiotics14010102.
Isorhamnetin: what is the evidence for its antitumor potential and beyond?.
Lei J, Yang J, Bao C, Lu F, Wu Q, Wu Z Front Pharmacol. 2024; 15:1309178.
PMID: 38650631 PMC: 11033395. DOI: 10.3389/fphar.2024.1309178.
References
1.
Chattopadhyay K, Kapoor N, Heinrich M, Mitra A, Mittal M, Lewis S
. Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners. Front Med (Lausanne). 2023; 10:1043715.
PMC: 9922832.
DOI: 10.3389/fmed.2023.1043715.
View
2.
Gagnier J, Boon H, Rochon P, Moher D, Barnes J, Bombardier C
. Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration. J Clin Epidemiol. 2006; 59(11):1134-49.
DOI: 10.1016/j.jclinepi.2005.12.020.
View
3.
Schulz K, Altman D, Moher D
. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332.
PMC: 2844940.
DOI: 10.1136/bmj.c332.
View
4.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N
. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843.
DOI: 10.1016/j.diabres.2019.107843.
View
5.
Chattopadhyay K, Wang H, Kaur J, Nalbant G, Almaqhawi A, Kundakci B
. Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis. Front Pharmacol. 2022; 13:821810.
PMC: 9213670.
DOI: 10.3389/fphar.2022.821810.
View